These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12550114)

  • 21. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
    D'Agnano I; Valentini A; Fornari C; Bucci B; Starace G; Felsani A; Citro G
    Oncogene; 2001 May; 20(22):2814-25. PubMed ID: 11420693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
    Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
    J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
    Cerutti J; Trapasso F; Battaglia C; Zhang L; Martelli ML; Visconti R; Berlingieri MT; Fagin JA; Santoro M; Fusco A
    Clin Cancer Res; 1996 Jan; 2(1):119-26. PubMed ID: 9816098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
    Watson PH; Pon RT; Shiu RP
    Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides.
    Hegyesi H; Somlai B; Varga VL; Toth G; Kovacs P; Molnar EL; Laszlo V; Karpati S; Rivera E; Falus A; Darvas Z
    J Invest Dermatol; 2001 Jul; 117(1):151-3. PubMed ID: 11442763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
    Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
    J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
    Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
    Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of human c-myc oncogene expression by poly-DNP-RNA.
    Shen L; Zhang C; Ambrus JL; Wang JH
    Oligonucleotides; 2005; 15(1):23-35. PubMed ID: 15788898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of oncogene expression in subungual melanoma.
    Grover R; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Jan; 50(1):15-9. PubMed ID: 9038509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
    Grover R; Ross DA; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells.
    Chen JP; Chen L; Leek J; Lin C
    Eur J Clin Invest; 2006 Jan; 36(1):49-57. PubMed ID: 16403010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
    Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
    J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
    Shi Y; Hutchinson HG; Hall DJ; Zalewski A
    Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.
    Welch DR; Bisi JE; Miller BE; Conaway D; Seftor EA; Yohem KH; Gilmore LB; Seftor RE; Nakajima M; Hendrix MJ
    Int J Cancer; 1991 Jan; 47(2):227-37. PubMed ID: 1671030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.
    Böni R; Bantschapp O; Müller B; Burg G
    Dermatology; 1998; 196(3):288-91. PubMed ID: 9621133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.